ALPS Medical Breakthroughs ETF (SBIO)

Add to Watchlists
Create an Alert
28.58 +0.45  +1.60% NYSE Arca Jun 23, 20:00 Delayed 2m USD
View Full Chart
SBIO Price Chart

SBIO Key Stats

SBIO Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 12.44% 7.50% 2
3M 12.92% 10.30% 13
6M 20.90% 19.13% 32
1Y 22.29% 19.30% 28
3Y -- 10.02% --
5Y -- 18.23% --
As of June 23, 2017
Returns for periods of 1 year and above are annualized.

SBIO Asset Allocation

Type % Net % Long % Short
Cash 0.10% 0.11% 0.01%
Stock 99.90% 99.90% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00% 0.00% 0.00
As of May 31, 2017

SBIO Region Exposure

Americas 89.34%
North America 89.34%
Latin America 0.00
Greater Europe 10.66%
United Kingdom 2.56%
Europe Developed 7.40%
Europe Emerging 0.00
Africa/Middle East 0.71%
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00
As of May 31, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

SBIO Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of May 31, 2017

SBIO Stock Market Capitalization

Giant 0.00
Large 0.00
Medium 23.48%
Small 53.95%
Micro 22.57%
As of May 31, 2017

SBIO Stock Style Exposure

Large Cap Value 0.00
Large Cap Blend 0.00
Large Cap Growth 0.00
Mid Cap Value 0.00
Mid Cap Blend 4.51%
Mid Cap Growth 20.06%
Small Cap Value 7.63%
Small Cap Blend 7.09%
Small Cap Growth 60.71%
As of May 31, 2017
View More Holdings

SBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
ALNY Alnylam Pharmaceuticals Inc 5.01% 85.21 +1.49%
IONS Ionis Pharmaceuticals Inc 4.82% 54.97 +0.46%
EXEL Exelixis Inc 4.10% 23.78 -1.20%
TARO Taro Pharmaceutical Industries Ltd 3.90% 116.06 +1.79%
AKRX Akorn Inc 3.69% 33.53 +0.00%
KITE Kite Pharma Inc 3.53% 100.66 +7.10%
GLPG Galapagos NV ADR 3.38% 79.00 +0.56%
NBIX Neurocrine Biosciences Inc 3.37% 47.35 +0.49%
ACAD ACADIA Pharmaceuticals Inc 2.77% 29.24 +1.95%
BLUE bluebird bio Inc 2.74% 112.00 -5.49%
As of May 31, 2017
Advertisement

SBIO Ratings

Fiduciary Score Upgrade

SBIO One Page Reports

SBIO Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name ALPS
Benchmark Index
Poliwogg Medical Breakthroughs TR USD
100.0%

SBIO Manager Info

Name Tenure
Andrew Hicks 1.08 yrs
Michael Akins 2.34 yrs
Ryan Mischker 2.09 yrs

SBIO Net Fund Flows

1M 4.892M
3M 3.643M
6M -16.29M
YTD -3.665M
1Y -33.37M
3Y --
5Y --
10Y --
As of May 31, 2017

SBIO Risk Info

Beta (5Y) --
Max Drawdown (All) 49.69%
Historical Sharpe (10Y) --
Historical Sortino (All) 0.2488
30-Day Rolling Volatility 24.40%
Daily Value at Risk (VaR) 1% (All) 6.69%
Monthly Value at Risk (VaR) 1% (All) 27.20%

SBIO Fundamentals

Dividend Yield TTM (6-23-17) 0.00
SEC Yield (3-31-17) -0.38%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 6.015
Weighted Average Price to Book Ratio 4.064
Weighted Median ROE -30.81%
Weighted Median ROA -25.38%
Forecasted Dividend Yield 0.01%
Forecasted PE Ratio 22.68
Forecasted Price to Sales Ratio 4.350
Forecasted Price to Book Ratio 2.584
Number of Holdings 86
As of May 31, 2017

SBIO Growth Estimates

Forecasted 5 Yr Earnings Growth 21.72%
Forecasted Book Value Growth 13.53%
Forecasted Cash Flow Growth 32.55%
Forecasted Earnings Growth -11.31%
Forecasted Revenue Growth 1.27%
As of May 31, 2017

SBIO Comparables

Edit

SBIO Attributes

Key Dates
Inception Date 12/30/2014
Last Annual Report Date 11/30/2016
Last Prospectus Date 3/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

SBIO Excel Add-In Codes

  • Name: =YCI("SBIO","name")
  • Broad Asset Class: =YCI("SBIO", "broad_asset_class")
  • Broad Category: =YCI("SBIO", "broad_category_group")
  • Prospectus Objective: =YCI("SBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.